SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-025017
Filing Date
2018-09-21
Accepted
2018-09-21 17:29:37
Documents
2
Period of Report
2018-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1550
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4015
  Complete submission text file 0000899243-18-025017.txt   7067
Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Pottage John C Jr (Reporting) CIK: 0001378587 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38266 | Film No.: 181082262

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations